Concepedia

Luminita Ocroteala

LO

Statistics

Publications

3

Citations

243

H-Index

3

Active since

2014

Affiliations

The Catholic University of Korea Seoul St. Mary's Hospital(Current)

University Hospital in Halle

Catholic University of Korea

Assistance Publique – Hôpitaux de Paris

Inserm

Luminita Ocroteala is an author at The Catholic University of Korea Seoul St. Mary's Hospital specializing in clinical pharmacology, pharmacology, and medicine.

Publications per year

2014–2023

3

Publications

3

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

, , +9

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study

Aaron T. Gerds, Srđan Verstovšek, Alessandro M. Vannucchi et al. · The Lancet Haematology · 2023 · 39 citations

, , +8

Abstract 3847: The anti-hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) as treatment of anemia of chronic disease in patients with multiple myeloma, low grade lymphoma, and CLL: A phase II pilot study

Pencho Georgiev, Mihaela Lazaroiu, Luminita Ocroteala et al. · Cancer Research · 2014 · 19 citations

, , +17

1–3 of 3